JP2017503840A5 - - Google Patents

Download PDF

Info

Publication number
JP2017503840A5
JP2017503840A5 JP2016548158A JP2016548158A JP2017503840A5 JP 2017503840 A5 JP2017503840 A5 JP 2017503840A5 JP 2016548158 A JP2016548158 A JP 2016548158A JP 2016548158 A JP2016548158 A JP 2016548158A JP 2017503840 A5 JP2017503840 A5 JP 2017503840A5
Authority
JP
Japan
Prior art keywords
oxo
phenyl
carbonitrile
methyl
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016548158A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017503840A (ja
JP6530758B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/012579 external-priority patent/WO2015112792A1/en
Publication of JP2017503840A publication Critical patent/JP2017503840A/ja
Publication of JP2017503840A5 publication Critical patent/JP2017503840A5/ja
Application granted granted Critical
Publication of JP6530758B2 publication Critical patent/JP6530758B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016548158A 2014-01-24 2015-01-23 抗酸化性炎症調節剤としてのアリールおよびアリールアルキル置換されたピラゾリルおよびピリミジニル三環式エノン類 Active JP6530758B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461931291P 2014-01-24 2014-01-24
US61/931,291 2014-01-24
PCT/US2015/012579 WO2015112792A1 (en) 2014-01-24 2015-01-23 Aryl and arylalkyl substituted pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators

Publications (3)

Publication Number Publication Date
JP2017503840A JP2017503840A (ja) 2017-02-02
JP2017503840A5 true JP2017503840A5 (https=) 2018-03-01
JP6530758B2 JP6530758B2 (ja) 2019-06-12

Family

ID=52484552

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016548158A Active JP6530758B2 (ja) 2014-01-24 2015-01-23 抗酸化性炎症調節剤としてのアリールおよびアリールアルキル置換されたピラゾリルおよびピリミジニル三環式エノン類

Country Status (8)

Country Link
US (1) US9464082B2 (https=)
EP (1) EP3097089B1 (https=)
JP (1) JP6530758B2 (https=)
CN (1) CN107074801B (https=)
CA (1) CA2936550C (https=)
MX (1) MX372772B (https=)
TW (1) TWI670263B (https=)
WO (1) WO2015112792A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2721665C (en) 2008-04-18 2017-01-24 Reata Pharmaceuticals, Inc. Compounds including an anti-inflammatory pharmacore and methods of use
WO2009129546A1 (en) 2008-04-18 2009-10-22 Reata Pharmaceuticals, Inc. Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at c-17
JP6410710B2 (ja) 2012-04-27 2018-10-24 リアタ ファーマシューティカルズ インコーポレイテッド バルドキソロンメチルの2,2−ジフルオロプロピオンアミド誘導体、その多形体および使用方法
US9512094B2 (en) 2012-09-10 2016-12-06 Reata Pharmaceuticals, Inc. C17-heteroaryl derivatives of oleanolic acid and methods of use thereof
TWI649330B (zh) 2013-04-24 2019-02-01 艾伯維有限公司 甲基巴多索龍之2,2-二氟丙醯胺衍生物、其多晶形及其使用方法
CN107428698B (zh) * 2015-02-12 2021-10-26 里亚塔医药公司 作为抗氧化炎症调节剂的咪唑基三环烯酮
BR112019010511A2 (pt) 2016-11-23 2019-09-17 Bayer Ag derivados de heterociclo bicíclico fundido como pesticidas
TWI831738B (zh) * 2016-12-16 2024-02-11 美商瑞塔醫藥有限責任公司 用於抑制RORγ及其他用途的嘧啶三環烯酮衍生物
IL279348B2 (en) * 2018-06-15 2026-01-01 Reata Pharmaceuticals Inc Decahydro-2h-naphth[1,2-d]imidazole compounds for inhibition of IL-17 and ROR-gamma
WO2019246461A1 (en) 2018-06-20 2019-12-26 Reata Pharmaceuticals, Inc. Cysteine-dependent inverse agonists of nuclear receptors ror-gamma/ror-gamma-t and methods of treating diseases or disorders therewith
US20250025465A1 (en) * 2021-11-17 2025-01-23 Northwestern University Wt-idh1 inhibition using a covalent and brain-penetrant small molecular inhibitor for ferroptosis induction in high-grade glioma

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1142889A1 (en) 2000-04-03 2001-10-10 Pfizer Products Inc. Pyrazole derivatives as anti-inflammatory/analgesic agents
JP2005507892A (ja) * 2001-09-19 2005-03-24 ファルマシア・コーポレーション 炎症の治療のための置換されたピラゾリルベンゼンスルファミド化合物
MX357596B (es) 2010-04-12 2018-07-16 Reata Pharmaceuticals Inc Método para tratar obesidad utilizando moduladores de inflamación con antioxidantes.
PL2651902T3 (pl) * 2010-12-17 2018-04-30 Reata Pharmaceuticals, Inc. Pirazolilowe i pirymidynylowe tricykliczne enony jako modulatory zapalenia o działaniu przeciwutleniającym

Similar Documents

Publication Publication Date Title
JP2017503840A5 (https=)
JP2005536475A5 (https=)
WO2017090002A4 (en) Inhibitors of pi3 kinases
JP2021512150A5 (https=)
RU2014152790A (ru) Пирролопиразоновые ингибиторы танкиразы
JP2015528018A5 (https=)
CY1116769T1 (el) Υποκατεστhmενα παραγωγα βενζαμιδιου
RU2016141647A (ru) ИНГИБИТОРЫ TrkA КИНАЗЫ, ОСНОВАННЫЕ НА НИХ КОМПОЗИЦИИ И СПОСОБЫ
JP2015503507A5 (https=)
JP2008509187A5 (https=)
JP2016538313A5 (https=)
JP2013544893A5 (https=)
AU2013213260A1 (en) Imidazopyrrolidinone compounds
RU2350616C2 (ru) Производные пиразоло- и имидазопиримидина
JP2013509392A5 (https=)
CY1110676T1 (el) ΠΥΡΑΖΟΛΟ[3,4-b]ΠΥΡΙΔΙΝΙΚΕΣ ΕΝΩΣΕΙΣ, ΚΑΙ Η ΧΡΗΣΗ ΤΟΥΣ ΩΣ ΑΝΑΣΤΟΛΕΙΣ ΤΗΣ ΦΩΣΦΟΔΙΕΣΤΕΡΑΣΗΣ
RU2013148405A (ru) Ингибиторы киназ
JP2017533968A5 (https=)
NZ630721A (en) Pyrazolo[1,5-a]pyrimidine-based compounds, compositions comprising them, and methods of their use
RU2018112237A (ru) Новые бициклические соединения в качестве дуальных ингибиторов atx/ca
JP2016519685A5 (https=)
RU2007132262A (ru) Соединения и композиции в качестве ингибиторов протеинкиназ
RU2012112050A (ru) Производные дигидроптеридинона, способ их получения и фармацевтическое применение
JP2017502940A5 (https=)
JP2014500265A5 (https=)